European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocol
一项欧洲多中心前瞻性观察性IV期临床研究，旨在评估lebrikizumab对中重度特应性皮炎患者健康相关福祉和皮肤表现控制的影响（ADTrust）：研究方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-102155
Augustin, Matthias; Bewley, Anthony; Brüggen, Marie-Charlotte; de Bruin-Weller, Marjolein S; Ezzedine, Khaled; Ferrucci, Silvia M; Gkalpakiotis, Spyridon; Herranz, Pedro; Johansson, Emma K; Kampe, Tomáš; Lapeere, Hilde; Legat, Franz J; Rehbinder, Eva Maria; Szepietowski, Jacek C; Torres, Tiago; Vestergaard, Christian; Werfel, Thomas; Domenech, Arnau; Massana, Eric; Koscielny, Volker; Narayanan, Siva; Kasujee, Ismail; Gutermuth, Jan
